Skip to content
Clinical Trials – home

Soedersjukhuset AB

VerifiedinfoResponsive

Sweden Sjukhusbacken 10, Hogalid, 118 61 Stockholm, Sweden

  • 35 trials recruiting
  • Breast cancer · Prostate cancer metastatic · Colorectal cancer
  • Adults and children

About Specializations

Soedersjukhuset AB in Stockholm, Sweden specialises in clinical trials of conditions such as Breast cancer, Prostate cancer metastatic, Colorectal cancer, Breast cancer metastatic, and other specialisations. This site conducts important research.

Main research areas of the site

Neurology

The medical center is at the forefront of neurology research, with a particular focus on pediatric conditions. The ongoing studies aim to enhance the understanding and treatment of neurological disorders in children and adolescents.

  • Pediatric Migraine Management
  • Neurodevelopmental Disorders
  • Innovative Neurological Therapies

Through its research, the center is contributing to the development of safer and more effective treatments for young patients, improving their quality of life and long-term health outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Sjukhusbacken 10, Hogalid118 61 StockholmSweden
Recruiting now
35 trials
Conditions studied
66
Partner status
Verified

More sites in StockholmSweden

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

79 clinical trials

Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Bevacizumab
  • Sponsor:Amgen Inc.
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:GSK5764227
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Tozorakimab
  • Sponsor:AstraZeneca AB
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen Cilag International
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Unicancer
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:HUMANISED IGG1 LALAPS-YTE MONOCLONAL ANTIBODY AGAINST LYSOPHOSPHATIDIC ACID RECEPTOR 1
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Danicamtiv
  • Sponsor:Kardigan Inc.
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Pfizer Inc.
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.